Boston Scientific (BSX:ASX) Annual Reports & Investor Relations Material

Overview

Boston Scientific Corporation is a global leader in the development, manufacture, and marketing of medical devices for use in interventional medical specialties. With operations in the MedSurg and Cardiovascular segments, the company's offerings include state-of-the-art devices to diagnose and treat a variety of medical conditions, such as gastrointestinal and pulmonary issues, urological and pelvic disorders, and heart rate and rhythm disorders. Its portfolio also includes cutting-edge technologies for spinal cord stimulation and deep brain stimulation. In addition, Boston Scientific provides interventional cardiology products for the treatment of coronary artery disease and aortic valve conditions, including stents, balloon catheters, guidewires, atherectomy, and thrombectomy systems. The company also offers an array of peripheral embolization devices, radioactive microspheres, cryotherapy ablation systems, and micro and drainage catheters for the treatment of cancer. Founded in 1979 and headquartered in Marlborough, Massachusetts, Boston Scientific is committed to innovative solutions that promote better patient outcomes. Its dedication to advancing medical technologies has cemented its position as a global leader in the industry.

Frequently Asked Questions

What is Boston Scientific's ticker?

Boston Scientific's ticker is BSX

What exchange is Boston Scientific traded on?

The company's shares trade on the ASX stock exchange

Where are Boston Scientific's headquarters?

They are based in West Perth, Australia

How many employees does Boston Scientific have?

There are 11-50 employees working at Boston Scientific

What is Boston Scientific's website?

It is bostonscientific.com/en-US/Home.html

What type of sector is Boston Scientific?

Boston Scientific is in the Basic Materials sector